ABSTRACT
Targeted radionuclide treatments with alpha particle emitting isotopes have physical and radiobiological advantages over those with beta particles. Because of these advantages, alpha radionuclide treatments have found a developing research area. In this review, besides the physical properties of alpha particles, some radiobiological properties were examined, and the concept of relative biological effectiveness was emphasized.
Keywords:
Alpha radionuclide therapies, radiobiology, linear energy transfer, relative biological effectiveness
References
1
McDevitt MR, Sgouros G, Finn RD, et al. Radioimmunotherapy with alpha-emitting nuclides. Eur J Nucl Med 1998;25:1341-1351.
2
Morgenstern A, Apostolidis C, Kratochwil C, Sathekge M, Krolicki L, Bruchertseifer F. An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth. Curr Radiopharm 2018;11:200-208.
3
Parida GK, Panda RA, Bishnoi K, Agrawal K. Efficacy and Safety of Ac-225 PSMA Radio Ligand Therapy in Metastatic Prostate Cancer. A Systematic Review and Metanalysis. Med Princ Pract 2023.
4
Lee DY, Kim YI. Effects of 225Ac-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis. J Nucl Med 2022;63:840-846.
5
Kratochwil C, Giesel FL, Bruchertseifer F, et al. ²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience. Eur J Nucl Med Mol Imaging 2014;41:2106-2119.
6
Podgorsak EB. Radiation Physics for Medical Physicists. 2nd Edition. Heidelberg: Springer-Verlag; 2010.
7
Knoll GF. Radiation Detection and Measurement. 4th Edition. New Jersey: John Wiley & Sons, Inc.; 2010.
8
Piroozfar B, Raisali G, Alirezapour B, et al. The effect of 111In radionuclide distance and auger electron energy ondirect induction of DNA double-strand breaks: a Monte Carlo study using Geant4 toolkit. Int J Radiat Biol 2018;94:385-393.
9
Sgouros G, Roeske JC, McDevitt MR, et al. MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy. J Nucl Med 2010;51:311-328.
10
Bushberg JT, Seibert JA, Leidholdt EM, et al. The Essential Physics of Medical Imaging. 3rd Edition. Philadelphia: Lippincott Williams & Wilkins; 2012.
11
Zirkle RE. Some effects of alpha radiation upon plant cells. J Cell Comp Physiol. 1932;2:251-274.
12
Goodhead DT, Munson RJ, Thacker J, Cox R. Mutation and inactivation of cultured mammalian cells exposed to beams of accelerated heavy ions. IV. Biophysical interpretation. Int J Radiat Biol Relat Stud Phys Chem Med 1980;37:135-167.
13
Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985;58:515-528.
14
Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. 7th Edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2012.
15
Barendsen GW. Modification of radiation damage by fractionation of dose anoxia and chemical protectors in relation to LET. Ann N Y Acad Sci 1964;114:96-114.
16
Dale RG, Jones B. The assessment of RBE effects using the concept of biologically effective dose. Int J Radiat Oncol Biol Phys 1999;43:639-645.
17
Holthusen H. Articles on the biology of radiation effects: analysis on nematode eggs. Pflugers Arch Gesamte Physiol Menschen Tiere. 1921;187:1-24.
18
Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-549.
19
Saha GB. Physics and Radiobiology of Nuclear Medicine. 4th Edition. New York: Springer; 2013.
20
Barendsen GW, Koot CJ, Van Kersen GR, Bewley DK, Field SB, Parnell CJ. The effect of oxygen on impairment of the proliferative capacity of human cells in culture by ionizing radiations of different LET. Int J Radiat Biol Relat Stud Phys Chem Med 1966;10:317-327.
21
Ewing D, Powers EL. Oxygen-dependent sensitization of irradiated cells. In: Meyn RE, Withers HR, editors. Radiation Biology in Cancer Research. New York, NY: Raven Press; 1979.
22
Feinendegen LE, McClure JJ. Meeting report: Alpha-emitters for medical therapy Workshop of the United States Department of Energy, Denver, Colorado, May 30-31, 1996. Radiat Res 1997;148:195-201.
23
Kratochwil C, Bruchertseifer F, Giesel FL, et al. 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer. J Nucl Med 2016;57:1941-1944.
24
Kratochwil C, Schmidt K, Afshar-Oromieh A, et al. Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617. Eur J Nucl Med Mol Imaging 2018;45:31-37.
25
ICRP Publication 60: 1990 Recommendations of the International Commission on Rabiological Protection. Ann ICRP; 1991.
26
ICRP Publication 105: Radiological Protection in Medicine. Ann ICRP; 2008.
27
ICRP Publication 92: Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (WR), Ann ICRP; 2003.
